Praxis Precision Medicines Investor Relations Material
Latest events
R&D Day 2023
Praxis Precision Medicines
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders. The company has has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, including several clinical-stage product candidates. Praxis was founded in 2015, and is headquartered in Boston, Massachusetts, United States.
Key slides for Praxis Precision Medicines Inc
R&D Day 2023
Praxis Precision Medicines Inc
R&D Day 2023
Praxis Precision Medicines Inc
Latest articles
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
Ticker symbol
PRAX
Country
🇺🇸 United States